BRIEF published on 01/28/2025 at 07:35, 1 year 4 months ago Nicox: Participation in Major Congresses in 2025 Investment Ophthalmology Congress Nicox NCX 470
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 4 months ago Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Nicox annonce sa participation à des congrès internationaux en ophtalmologie et finance au premier semestre 2025, y compris l'AGS 2025 Congrès Annuel Finance Ophtalmologie Congrès Nicox AGS 2025
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year 4 months ago Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025 Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF published on 01/22/2025 at 07:35, 1 year 5 months ago Nicox maintient son éligibilité au PEA-PME PEA-PME Investissement Euronext Ophtalmologie Nicox
BRIEF published on 01/22/2025 at 07:35, 1 year 5 months ago Nicox maintains its eligibility for the PEA-PME PEA-PME Euronext Investment Ophthalmology Nicox
PRESS RELEASE published on 01/22/2025 at 07:30, 1 year 5 months ago Nicox confirme son éligibilité au PEA-PME Nicox confirme son éligibilité au PEA-PME pour les 12 prochains mois, ouvrant la voie à l'investissement dans les petites et moyennes valeurs en ophtalmologie. Pour plus d'informations, consultez www.nicox.com PEA-PME Investissement Éligibilité Ophtalmologie Nicox
BRIEF published on 01/21/2025 at 07:35, 1 year 5 months ago Nicox : Résumé financier et activités du quatrième trimestre 2024 Résultats Financiers Trésorerie Nicox NCX 470 Quatrième Trimestre 2024
BRIEF published on 01/21/2025 at 07:35, 1 year 5 months ago Nicox: Fourth Quarter 2024 Financial and Business Summary Financial Results Treasury Nicox NCX 470 Fourth Quarter 2024
PRESS RELEASE published on 01/21/2025 at 07:30, 1 year 5 months ago Nicox : Point d’activité et résumé financier du quatrième trimestre 2024 Nicox annonce les résultats financiers du quatrième trimestre 2024, avec recrutement du dernier patient pour NCX 470 Denali et revenu de 13,7M€, trésorerie de 10,7M€. Prévisions et stratégies pour 2025 Résultats Financiers Stratégie 2025 Trimestre 2024 Nicox NCX 470 Denali
PRESS RELEASE published on 01/21/2025 at 07:30, 1 year 5 months ago Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Nicox provides Q4 2024 financial highlights, including €13.7 million revenue and €10.7 million cash. Final patient enrolled in NCX 470 trial, with results expected in Q3 2025 Financial Highlights Nicox Q4 2024 Q3 2025 NCX 470 Trial
Published on 06/26/2026 at 01:40, 5 hours 55 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 8 hours 5 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 9 hours 5 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 10 hours 3 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 16 hours 5 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 04:20, 3 hours 15 minutes ago VARON Helps Travelers Breathe Easy This Summer With Portable Oxygen Concentrators Built for Mobility
Published on 06/26/2026 at 02:05, 5 hours 30 minutes ago VARON Marks "Love Your Lungs Week" With a Call to Prioritize Summer Respiratory Health Across Europe
Published on 06/25/2026 at 22:40, 8 hours 55 minutes ago DeFi Technologies Inc. Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
Published on 06/25/2026 at 19:00, 12 hours 34 minutes ago EQS-Adhoc: H&R GmbH & Co. KGaA resolves to prepare for the transition from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 06/25/2026 at 18:59, 12 hours 36 minutes ago OHB Digital Connect completes upgrade of military ground stations
Published on 06/26/2026 at 07:00, 35 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 35 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 12 hours 50 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 13 hours 5 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 13 hours 45 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
